Functional improvement in chronic human spinal cord injury: Four years after acidic fibroblast growth factor
Abstract Few treatments have proven effective for patients with chronic spinal cord injury (SCI). This study aimed to evaluate the efficacy and safety of acidic fibroblast growth factor (aFGF) in human SCI. This was an open-label prospective clinical trial of aFGF with an extended follow-up to 48 mo...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2018-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-018-31083-4 |